ask="2.26"
ask_size="1000"
average_daily_volume="444166"
bid="2.21"
bid_size="5000"
book_value="4.01"
change="-0.01"
change_from_200_day_moving_average="-3.06"
change_from_50_day_moving_average="0.06"
change_from_52_week_high="-7.11"
change_From_52_week_low="0.24"
change_in_percent="-0.44%"
close="2.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.96"
ebitda="-30.59M"
eps_estimate_current_year="-2.08"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.69"
ex_dividend_date="N/A"
float_shares="8428000"
high="2.29"
high_52_weeks="9.35"
last_trade_date="1/18/2017"
last_trade_price="2.24"
last_trade_size="300"
last_trade_time="4:00pm"
low="2.20"
low_52_weeks="2.00"
market_capitalization="34.82M"
moving_average_200_day="5.30"
moving_average_50_day="2.18"
name="Nivalis Therapeutics
Inc."
notes="N/A"
one_year_target_price="12.08"
open="2.26"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-57.77%"
percent_change_from_50_day_moving_average="+2.52%"
percent_change_from_52_week_high="-76.04%"
percent_change_from_52_week_low="+12.00%"
previous_close="2.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.56"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="15543000"
short_ratio="0.50"
stock_exchange="NGM"
symbol="NVLS"
volume="237160"
weeks_range_52="2.00 - 9.35"
